Concepedia

Abdul Miah

AM

Statistics

Publications

10

Citations

299

H-Index

10

Active since

2016

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University Wexner Medical Center

University of Washington

Ohio State University Hospital

Abdul Miah is an author at The Ohio State University specializing in oncology, checkpoint inhibitor therapy, and immunotherapy.

ORCID

Publications per year

2016–2023

10

Publications

10

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak et al. · BMC Cancer · 2020 · 61 citations · Full text

, , +14

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

Angel Qin, Songzhu Zhao, Abdul Miah et al. · Journal of the National Comprehensive Cancer Network · 2021 · 53 citations · Full text

, , +17

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Tyler Haddad, Songzhu Zhao, Mingjia Li et al. · Cancer Immunology Immunotherapy · 2021 · 47 citations · Full text

, , +17

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Mingjia Li, Daniel Spakowicz, Songzhu Zhao et al. · Cancer Immunology Immunotherapy · 2020 · 44 citations · Full text

, , +16

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

Evan Gross, Mingjia Li, Ming Yin et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 26 citations · Full text

, , +16

1–5 of 10